151Basiliximab (Simulect ®) is safe and well tolerated in adult liver transplantation and provides a low rate of acute rejection

Saved in:
Bibliographic Details
Published inLiver transplantation Vol. 6; no. 3; p. C38
Main Authors Calmus, Y., Scheele, J., Gonzalez-Pinto Arrillaga, I., Jaurriela Mas, E., Klar, E., Pageaux, G., Scudamore, C., Cuervas-Mons Martinez, V., Metselaar, H.J., Girault, D.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.05.2000
Online AccessGet full text

Cover

More Information
ISSN:1527-6465
1527-6473
DOI:10.1016/S1527-6465(05)80179-0